SCHEMBL1308565

SCHEMBL1308565

COc1cc(C(=O)c2cc(-c3cnc(C)s3)ccc2NC(C)=O)cc(OC)c1OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.51
LMNA P02545 1/20 0.51
ABCB1 P08183 5/20 0.48
TUBB4A P04350 8/20 0.47
TUBB P07437 8/20 0.47
TUBA3C P0DPH7 8/20 0.47
TUBA1B P68363 8/20 0.47
TUBA4A P68366 8/20 0.47
TUBB4B P68371 8/20 0.47
TUBB3 Q13509 8/20 0.47
TUBB2A Q13885 8/20 0.47
TUBB8 Q3ZCM7 8/20 0.47
TUBA3E Q6PEY2 8/20 0.47
TUBA1A Q71U36 8/20 0.47
TUBA1C Q9BQE3 8/20 0.47
TUBB6 Q9BUF5 8/20 0.47
TUBB2B Q9BVA1 8/20 0.47
TUBB1 Q9H4B7 8/20 0.47
MAPT P10636 1/20 0.44
ABCC1 P33527 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1308711 0.89 TUBB4A (0.50) SMN1; SMN2LMNAABCB1TUBB4ATUBB
SCHEMBL1308202 0.81 ABCB1 (0.62) SMN1; SMN2LMNAABCB1TUBB4ATUBB
SCHEMBL1308664 0.80 LMNA (0.56) SMN1; SMN2LMNAABCB1TUBB4ATUBB
SCHEMBL12113114 0.80 SMN1; SMN2 (0.51) SMN1; SMN2LMNAABCB1TUBB4ATUBB
SCHEMBL1307176 0.80 ABCB1 (0.55) SMN1; SMN2LMNAABCB1TUBB4ATUBB
SCHEMBL1308020 0.79 ABCB1 (0.64) SMN1; SMN2LMNAABCB1TUBB4ATUBB
SCHEMBL1308023 0.79 TUBB4A (0.54) SMN1; SMN2LMNAABCB1TUBB4ATUBB
SCHEMBL1307837 0.78 TUBB4A (0.61) SMN1; SMN2LMNAABCB1TUBB4ATUBB
SCHEMBL12116691 0.78 LMNA (0.60) SMN1; SMN2LMNAABCB1TUBB4ATUBB
SCHEMBL1307783 0.78 SMN1; SMN2 (0.51) SMN1; SMN2LMNAABCB1TUBB4ATUBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8053439-B2 Benzophenone derivatives useful for inhibiting formation of microtubule CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2011-11-08 US claimed
US-20090275575-A1 BENZOPHENONE DERIVATIVES USEFUL FOR INHIBITING FORMATION OF MICROTUBULE CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2009-11-05 US claimed
EP-2066632-A1 BENZOPHENONE DERIVATIVES USEFUL FOR INHIBITING FORMATION OF MICROTUBULE Chong Kun Dang Pharmaceutical Corp. (KR) 2009-06-10 EP claimed
WO-2008038955-A1 BENZOPHENONE DERIVATIVES USEFUL FOR INHIBITING FORMATION OF MICROTUBULE CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2008-04-03 WO claimed
EP-2066632-B1 BENZOPHENONE DERIVATIVES USEFUL FOR INHIBITING FORMATION OF MICROTUBULE CHONG KUN DANG PHARM CORP (KR) 2013-09-04 EP disclosed
US-8053439-B2 Benzophenone derivatives useful for inhibiting formation of microtubule CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2011-11-08 US disclosed
US-20090275575-A1 BENZOPHENONE DERIVATIVES USEFUL FOR INHIBITING FORMATION OF MICROTUBULE CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275575-A1 BENZOPHENONE DERIVATIVES USEFUL FOR INHIBITING FORMATION OF MICROTUBULE TUBB1, TUBA1C, TUBB6 SMN1; SMN2 1781/4885LMNA 1935/4885ABCB1 401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.